As a former Mint user, I had to find a new budgeting app not too long ago. Intuit, parent company of Mint, shut down the service in March 2024, and prompted users to transition to its other financial ...

Some offers mentioned below are no longer available. Even with good health insurance, medical bills can be a big out-of-pocket expense. If you can't cover these costs with a health savings account, ...

A 20-basis point reduction in expense ratio on a Rs 10 lakh portfolio over a 20-year period can translate into nearly Rs 2.95 lakh of additional wealth. SEBI has decided to cut mutual fund base ...

Changes to travel expense rules ahead of the last election have been dismissed by a senior minister as a simplification rather than an attempt to expand what can be billed to taxpayers. Addressing the ...

Rising use “is not a signal of satisfaction,” an author of a new report says. Rather, heavy users of the apps are under “financial strain.” By Ann Carrns Pay-advance apps are marketed as a way to help ...

SAP Concur and American Express Global Business Travel have partnered for a combined travel and expense offering that will be available to joint clients later this month, the companies announced. The ...

The median cost of a traditional funeral with burial and viewing is about $8,300, according to a 2023 report from the National Funeral Directors Association, the most recent data available. Cremation ...

Preoperative GLP-1 therapy may reduce surgical risks in obese patients without increasing perioperative complications, offering a scalable weight management strategy. Updated ASA guidelines recommend ...

Check both net and gross expense ratios when choosing funds; discounts may be temporary. Aim for funds with low expense ratios to enhance investment returns over time. Passively managed index funds ...

The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.

CHICAGO -- A neoadjuvant chemotherapy regimen of cisplatin (Platinol), nab-paclitaxel (Abraxane), capecitabine (Xeloda), and gemcitabine (PAXG) topped a standard option in a randomized trial of ...